Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2010
06/01/2010US7727441 forming the gel dispersion into a tube, extrusion to form a tubular tissue scaffold; comprising biopolymer fibers for use in propagation and culturing of tissues; tissue engineering and regenerative medicine; tissue grafting; prosthetics; cell therapy; useful in cardiovascular applications
06/01/2010CA2512040C Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection
06/01/2010CA2480727C Gene coding for acetolactate synthase
06/01/2010CA2424700C Genetic immunisation against cervical carcinoma
06/01/2010CA2393476C Dna sequence imparting cytoplasmic male sterility, mitochondrial genome, nuclear genome, mitochondria and plant containing said sequence and process for the preparation of hybrids
06/01/2010CA2353816C Compositions and methods for enhancement of major histocompatibility complex class i restricted antigen presentation
06/01/2010CA2336221C Human neuronal acid-sensitive cationic channels, its cloning and applications
06/01/2010CA2304376C Dna-construct for the tissue-specific expression of a blood coagulation factor
06/01/2010CA2288600C A method for making multispecific antibodies having heteromultimeric and common components
05/2010
05/27/2010WO2010060114A1 Chimeric pestivirus with insertion in 3' nontranslated region (3' ntr) with stable replication and rnase resistance
05/27/2010WO2010060096A2 Compositions and methods for increasing cellulose production
05/27/2010WO2010060080A1 Three dimensional tissue generation
05/27/2010WO2010060066A1 Substrate and method for culturing breast cells
05/27/2010WO2010059965A2 Methods and compositions for generating self attenuating genetic circuitry
05/27/2010WO2010059876A2 In vitro human b lymphopoiesis culture system
05/27/2010WO2010059862A2 Compositions and methods to generate pilosebaceous units
05/27/2010WO2010059828A1 Amnion derived adherent cells
05/27/2010WO2010059806A2 Generation of induced pluripotent stem cells without the use of viral vectors
05/27/2010WO2010059778A1 Methods and compositions for cell attachment and cultivation on planar substrates
05/27/2010WO2010059775A1 Pluripotent stem cell culture on micro-carriers
05/27/2010WO2010059738A1 Differentiation of stem cells into dopaminergic cells
05/27/2010WO2010059583A1 Spaced projection substrates and devices for cell culture
05/27/2010WO2010059401A2 Compounds that expand hematopoietic stem cells
05/27/2010WO2010059388A2 Cell delivery systems to induce cell growth and angiogenesis
05/27/2010WO2010058824A1 Substance for regulating differentiation into mesenchymal cell, and use thereof
05/27/2010WO2010058707A1 Fusion collagenase to which affinity tag is attached, and method for producing same
05/27/2010WO2010057965A1 Myometrial-derived mesenchymal stem cells
05/27/2010WO2010057614A1 Reprogramming cells toward a pluripotent state
05/27/2010WO2010057260A1 Method for treating or preventing a pancreatic dysfunction
05/27/2010WO2010037130A3 Compositions and methods of generating reprogrammed adipocyte cells and methods of use therefore
05/27/2010WO2010033925A3 Peptide-presenting surfaces for long-term culture of pluripotent cells
05/27/2010WO2010023463A3 Polymer blends
05/27/2010WO2010013947A3 Growth method for natural killer cells
05/27/2010WO2009155055A3 Methods of effecting wnt signaling through dkk structural analysis
05/27/2010WO2009099539A3 (meth)acrylate surfaces for cell culture, methods of making and using the surfaces
05/27/2010WO2003031572A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/27/2010WO1990007321A3 Lymphocyte receptor homing sequences and their uses
05/27/2010US20100132074 Method for modifying plant architecture and enhancing plant biomass and/or sucrose yield
05/27/2010US20100132072 Method to Increase Crop Grain Yield Utilizing Complementary Paired Growth and Yield Genes
05/27/2010US20100132070 Plant Defense Genes and Proteins and Methods of Use
05/27/2010US20100132069 Pathogen-inducible promoters and their use in enhancing the disease resistance of plants
05/27/2010US20100132062 Rice Mutant Allele
05/27/2010US20100132061 Novel soybean 75155
05/27/2010US20100132060 Therapeuting compositions comprising an rnai agent and a neurotrophic factor and methods of use thereof
05/27/2010US20100132059 Temperature-induced polynucleotides and uses therefor
05/27/2010US20100132055 Animal model for the selection and validation of agents active against pulmonary emphysema and colorectal cancer
05/27/2010US20100130729 Mu-1, member of the cytokine receptor family
05/27/2010US20100130598 Methods for inducing programmed cell death
05/27/2010US20100130596 Rad51 derived cancer cell specific promoters for targeted anti- cancer therapy
05/27/2010US20100130595 Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
05/27/2010US20100130585 Methods and compositions for investigation and treatment of cancer using a g-protein coupled eicosanoid receptor
05/27/2010US20100130571 Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
05/27/2010US20100130548 Biphenyl derivatives as modulators of voltage gated ion channels
05/27/2010US20100130544 Use of parasympatholytic substances to enhance and accelerate stem cell differentiation, related methods and compositions
05/27/2010US20100130490 Csf-1r inhibitors,compositions, and methods of use
05/27/2010US20100130476 Compounds that induce pancreatic beta-cell expansion
05/27/2010US20100130467 Triazolotriazines as kinase inhibitors
05/27/2010US20100130449 Use of Tri-Substituted Glycerol Compounds for the Treatment of Radiation Injuries
05/27/2010US20100130423 Treatment of myeloproliferative disorders with adaptor protein lnk
05/27/2010US20100130420 Novel chimeric ligand-gated ion channels and methods of use thereof
05/27/2010US20100130419 Artery- and Vein-Specific Proteins and Uses Therefor
05/27/2010US20100130414 Methods of Using E2F2 for the Treatment of Hypertension
05/27/2010US20100130412 Compositions to prevent and treat type-1 diabetes
05/27/2010US20100130408 Use of modified cyclosporins
05/27/2010US20100130405 Biglycan and related therapeutics and methods of use
05/27/2010US20100129931 Anti-Methylation-Controlled J Protein Antibodies and Uses Thereof
05/27/2010US20100129915 Methods for inducing cardiomyogenesis
05/27/2010US20100129914 Tol1 FACTOR TRANSPOSASE AND DNA INTRODUCTION SYSTEM USING THE SAME
05/27/2010US20100129913 Polioma vector expressing long double-stranded rnas
05/27/2010US20100129912 3D Cell-Culture Article and Methods Thereof
05/27/2010US20100129911 Nanoparticulate Affinity Capture for Label Independent Detection System
05/27/2010US20100129910 Cell matrix related compositions and their use for generating embryoid bodies
05/27/2010US20100129909 Device and method for treating biomass
05/27/2010US20100129908 Spaced projection substrates and devices for cell culture
05/27/2010US20100129907 Human foreskin fibroblast conditioned media for culturing es cells
05/27/2010US20100129906 Method for Obtaining Xeno-Free Hbs Cell line
05/27/2010US20100129905 Mammalian cytokines; related reagents and methods
05/27/2010US20100129904 polynucleotide encoding a protein that is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b); for treating cancer responsive to interferon alpha therapy
05/27/2010US20100129903 Pitx3 expression promoters
05/27/2010US20100129901 Hepatitis c virus vaccine
05/27/2010US20100129869 Methods and compositions for inactivating glutamine synthetase gene expression
05/27/2010US20100129863 Optimized core promoters and uses thereof
05/27/2010US20100129845 Astaxanthine Biosynthesis in Eukaryotes
05/27/2010US20100129824 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
05/27/2010US20100129807 Stabilization of cyclic peptide structures
05/27/2010US20100129806 Regulation of cell survival by hsp90 and ip6k2
05/27/2010US20100129791 cDNA Encoding a Gene Bog (B5T Over-Expressed Gene) and its Protein Product
05/27/2010US20100129771 Method for production of tooth, and tooth produced by the method
05/27/2010US20100129463 Multi-formed collagenous biomaterial medical device for use in wound care
05/27/2010US20100129440 Embryonic-like stem cells derived from adult human peripheral blood and methods of use
05/27/2010US20100129438 Methods and Compositions for the Treatment and Prevention of HIV Infection Using TRIM5ALPHA
05/27/2010US20100129429 Inhibition of autophagy genes in cancer chemotherapy
05/27/2010US20100129399 Linear expression constructs for production of influenza virus particles
05/27/2010US20100129390 Dkk1 as a universal tumor vaccine for immunotherapy of cancers
05/27/2010US20100129386 bacterial polypeptides; inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis; kit comprising the polypeptide immobilized on a solid support
05/27/2010US20100129384 Taci-immunoglobulin fusion proteins
05/27/2010US20100129383 Bifunctional fusion molecules for the delivery of antigens to professional antigen-presenting cells
05/27/2010US20100129381 Nucleotide sequences coding fibroblast growth factor-19 specific immunoglobulin for use in prevention and treatment of tumors, cancer and/or cell proliferative disorders
05/27/2010US20100129380 Antibodies Against IL-25
05/27/2010US20100129374 Mammalian Cell Membrane Proteins; Related Reagents
1 ... 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 ... 1827